ASX AnnouncementsPositive preclinical data for deoxymabs in vasculitis9 Apr at 10:13 am0Patrys has announced that new data from preclinical studies using PAT-DX1 and PAT-DX3 in animal models of the autoimmune disease…
ASX AnnouncementsPotential to use Deoxymabs to treat autoimmune diseases 4 Mar at 10:25 am0Patrys has announced that new data from preclinical studies using PAT-DX1 in animal models of anti neutrophil cytoplasmic antibody (ANCA)…
ASX AnnouncementsQuarterly Activities Report and 4C | 31 December 202323 Jan at 12:29 pm0Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 31…
ASX AnnouncementsGMP Production of PAT-DX1 Next Quarter13 Dec 20230Patrys is pleased to announce that its Contract Manufacturing and Development Oganisation (CDMO) has confirmed that a manufacturing slot for…
ASX AnnouncementsPatrys Receives R&D Tax Incentive Refund8 Nov 20230Patrys has today announced that its wholly-owned subsidiary Nucleus Therapeutics Pty Ltd has received a $2.7 million refund for the…
Market AnnouncementQuarterly Activities Report and 4C Quarterly Cash Flow Report20 Oct 20230Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 30…
ASX AnnouncementsData to be presented at leading brain cancer conference19 Oct 20230Patrys is pleased to announce that data from preclinical studies using PAT-DX1 and PAT-DX3 in animal models of high grade…
ASX AnnouncementsRetirement of Non-Executive Director14 Sep 20230Patrys has today announced the retirement of Ms Suzy Jones as a Director of Patrys effective from close of business…
ASX AnnouncementsPatrys FY23 Annual Report28 Aug 20230Patrys has today released its Annual Report for the 2022-23 Financial Year (FY23). Highlights include: Successful completion of the PAT-DX1…
ASX AnnouncementsQuarterly Activities Report and 4C | 30 June 202326 Jul 20230Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 30…